We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $7.09B
1-Year Est. Return 20.73%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+20.73%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.56B
AUM Growth
+$203M
Cap. Flow
+$31.2M
Cap. Flow %
1.22%
Top 10 Hldgs %
26.64%
Holding
230
New
12
Increased
92
Reduced
116
Closed
6
Avg Time Held
4.2 quarters
Top 10 Avg Time Held
2.2 quarters
Top 20 Avg Time Held
4.4 quarters

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$63.7M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$36.6M
3
VGLT icon
Vanguard Long-Term Treasury ETF
VGLT
+$14.9M
4
SPTL icon
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
+$9.91M
5
UNH icon
UnitedHealth
UNH
+$6.29M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$18.7M
2
TMO icon
Thermo Fisher Scientific
TMO
+$10.9M
3
NVDA icon
NVIDIA
NVDA
+$8.8M
4
BSX icon
Boston Scientific
BSX
+$8.58M
5
AMD icon
Advanced Micro Devices
AMD
+$6.36M

Sector Composition

Rank Sector Weight
1 Healthcare 43.82%
2 Technology 19.48%
3 Miscellaneous 9.65%
4 Financials 6.91%
5 Consumer Discretionary 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TLT icon
1
iShares 20+ Year Treasury Bond ETF
TLT
$43.6B
$138M 5.4%
1,461,707
+673,084
+85% +$63.7M
2023 Q3
2 quarters
JNJ icon
2
Johnson & Johnson
JNJ
$617B
$69.3M 2.71%
438,157
-9,382
-2% -$1.49M
2022 Q4
5 quarters
UNH icon
3
UnitedHealth
UNH
$334B
$68.8M 2.69%
139,100
+12,378
+10% +$6.29M
2022 Q4
5 quarters
MRK icon
4
Merck
MRK
$356B
$60.7M 2.37%
459,937
-49,989
-10% -$6.16M
2022 Q4
5 quarters
ABBV icon
5
AbbVie
ABBV
$464B
$59.6M 2.33%
327,535
-24,564
-7% -$4.23M
2022 Q4
5 quarters
BSX icon
6
Boston Scientific
BSX
$61.7B
$57.7M 2.25%
842,700
-133,410
-14% -$8.58M
2022 Q4
5 quarters
SYK icon
7
Stryker
SYK
$106B
$57.4M 2.24%
160,533
-8,636
-5% -$2.91M
2022 Q4
5 quarters
ISRG icon
8
Intuitive Surgical
ISRG
$138B
$56.9M 2.22%
142,695
-10,267
-7% -$3.88M
2022 Q4
5 quarters
DHR icon
9
Danaher
DHR
$150B
$56.7M 2.22%
227,199
-18,531
-8% -$4.52M
2022 Q4
5 quarters
A icon
10
Agilent Technologies
A
$47.3B
$56.7M 2.21%
389,533
-20,327
-5% -$2.78M
2023 Q3
2 quarters
BMY icon
11
Bristol-Myers Squibb
BMY
$125B
$55.7M 2.17%
1,027,052
+21,897
+2% +$1.12M
2022 Q4
5 quarters
ELV icon
12
Elevance Health
ELV
$83.8B
$55.6M 2.17%
107,128
+645
+0.6% +$321K
2022 Q4
5 quarters
REGN icon
13
Regeneron Pharmaceuticals
REGN
$75.7B
$53.9M 2.1%
55,954
-5,047
-8% -$4.8M
2022 Q4
5 quarters
MDT icon
14
Medtronic
MDT
$110B
$53.7M 2.1%
616,401
-65,577
-10% -$5.6M
2022 Q4
5 quarters
AZN icon
15
AstraZeneca
AZN
$243B
$52.9M 2.07%
390,633
+3,260
+0.8% +$432K
2022 Q4
5 quarters
ABT icon
16
Abbott
ABT
$169B
$52.9M 2.06%
465,019
-51,974
-10% -$5.96M
2022 Q4
5 quarters
AMGN icon
17
Amgen
AMGN
$218B
$52.7M 2.06%
185,233
+188
+0.1% +$55K
2022 Q4
5 quarters
LLY icon
18
Eli Lilly
LLY
$1.02T
$52.2M 2.04%
67,067
-26,289
-28% -$18.7M
2022 Q4
5 quarters
TMO icon
19
Thermo Fisher Scientific
TMO
$242B
$51.4M 2.01%
88,410
-19,387
-18% -$10.9M
2022 Q4
5 quarters
NVS icon
20
Novartis
NVS
$268B
$46.9M 1.83%
484,971
-36,361
-7% -$3.73M
2022 Q4
5 quarters
ZTS icon
21
Zoetis
ZTS
$28.8B
$46.6M 1.82%
275,260
+4,695
+2% +$879K
2022 Q4
5 quarters
MSFT icon
22
Microsoft
MSFT
$3.84T
$41.8M 1.63%
99,266
+4,306
+5% +$1.74M
2022 Q4
5 quarters
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$4.2T
$40.5M 1.58%
268,176
-4,056
-1% -$580K
2022 Q4
5 quarters
TXN icon
24
Texas Instruments
TXN
$268B
$40M 1.56%
229,654
-5,621
-2% -$937K
2022 Q4
5 quarters
CSCO icon
25
Cisco
CSCO
$442B
$38.5M 1.5%
771,241
+121,944
+19% +$6.08M
2022 Q4
5 quarters
1
2 3 4 5

Similar funds

CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $7.06B AUM 27.24% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM

Harvest Portfolios Group's Q1 2024 Portfolio in Review

As of Q1 2024, Harvest Portfolios Group held 230 positions worth $2.56B, up 8.6% from $2.36B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Harvest Portfolios Group's Q1 2024 filing shows 12 new, 92 increased, 116 reduced and 6 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 386,152 shares worth $36.6M. The largest sale was Eli Lilly, an estimated $18.7M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Technology and Miscellaneous.

  • Harvest Portfolios Group's largest Q1 2024 buy was iShares 7-10 Year Treasury Bond ETF: 386,152 shares worth $36.6M.
  • Harvest Portfolios Group added most to iShares 20+ Year Treasury Bond ETF in Q1 2024, an estimated $63.7M increase.
  • Harvest Portfolios Group's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $18.7M.
  • Harvest Portfolios Group fully exited NovaGold Resources in Q1 2024, selling an estimated $492K.
  • Harvest Portfolios Group's ten largest holdings make up 27% of its $2.56B portfolio in Q1 2024.
  • Harvest Portfolios Group opened 12 new positions and closed 6 in Q1 2024.
  • Harvest Portfolios Group's portfolio value rose 8.6% quarter-over-quarter to $2.56B.

Based on Harvest Portfolios Group's 13F filing for Q1 2024, filed 14 May 2024.